Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 113, Issue 11, 2416-2425, March 12, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells
Blood Cho et al. 113: 2416

Supplemental materials for: Cho et al

BrdU assay
Splenocytes were cultured (16 h) in the presence of anti-IgM or anti-IgM + IL-4, and then pulsed 16 h with 5-bromo-2′-deoxyuridine (BrdU; 10 µM). After staining with anti-B220, cells were fixed with paraformaldehyde (4%), permeabilized with 0.2% Saponin, 1% FBS in PBS, re-fixed (4% paraformaldehyde), treated (30 min at 37°C) with 50 U DNase I (Roche), stained with Alexa647–anti-BrdU Ab (Invitrogen), and analyzed by flow cytometry.

TUNEL assays
Cells were fixed with 4% paraformaldehyde after surface staining with anti-B220, CD4, and CD8, permeabilized with 0.1% Triton-X-100–containing PBS, followed by standard reactions (30 min at 37°C) containing biotin-14-dCTP. Cells were then washed twice, stained with avidin-FITC (30 min on ice), washed twice, and analyzed. The extent of protection against apoptosis provided by IL-4 was analyzed both by the formula “% decrease in death” = {( % TUNEL+medium-only minus % TUNEL+IL-4–treated) divided by % TUNEL+medium-only and by calculation of “% rescued” = ( % TUNEL+medium-only) − (% TUNEL+IL-4–treated), yielding comparable and statistically significant results by each approach.

Micro-array screening for PARP-14–dependent IL-4–regulated gene expression
WT and PARP-14 KO B cells were purified by depleting Thy1+ cells and cultured 20 h in the presence or absence of IL-4 (4 ng/ml). RNA was isolated with TriZol reagent. Total RNA was amplified with Illumina RNA TotalPrep Amplification kit (Ambion), hybridized to Illumina’s Sentrix Mouse-6 WholeGenome BeadChip Arrays at 55°C for 18 h, and detected with 1 µg/ml Cyanine3-streptavidin (Amersham Biosciences). Chips were scanned with Illumina BeadArray Reader.

REFERENCES

Youn J, Chen J, Goenka S, et al. In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway disease. J Exp Med. 1998;188:1803–1816.

Stephenson L, Johns M H, Woodward E, Mora A L, Boothby M. An IL-4R alpha allelic variant, I50, acts as a gain-of-function variant relative to V50 for Stat6, but not Th2 differentiation. J Immunol. 2004;173:4523–4528.

Files in this Data Supplement:





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020